Veterinary Medicines

AviPro THYMOVAC Lyophilisate for use in drinking water

Authorised
  • Chicken anaemia virus, strain CUX-1, Live
Download as PDF

Product identification

Medicine name:
AviPro THYMOVAC Lyophilisate for use in drinking water
Avipro Thymovac vet. Frystorkat pulver för användning i dricksvatten
Active substance:
  • Chicken anaemia virus, strain CUX-1, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain CUX-1, Live
    31622.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • (ID10): 1 Box with 10 Bottle (Glass) with 10000 Dose (100000 Dose)
  • (ID9): 1 Box with 1 Bottle (Glass) with 10000 Dose (10000 Dose)
  • (ID8): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
  • (ID7): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)
  • (ID6): 1 Box with 10 Bottle (Glass) with 2500 Dose (25000 Dose)
  • (ID5): 1 Box with 1 Bottle (Glass) with 2500 Dose (2500 Dose)
  • (ID1): 1 Box with 1 Bottle (Glass) with 500 Dose (500 Dose)
  • (ID2): 1 Box with 10 Bottle (Glass) with 500 Dose (5000 Dose)
  • (ID4): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID3): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 26904
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0247/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 3/06/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 3/06/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 3/06/2024
Download

Combined File of all Documents

English (PDF)
Published on: 5/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."